Anticoagulation control and prediction of adverse events in patients with atrial brillation: a systematic review. Circ Cardiovasc Qual Outcomes. 2008;1(2):84-91. 154. Bjorck F, Renlund H, Lip GY, Wester P, Svensson PJ, Sjalander A. Outcomes in a warfarin-treated population with atrial brillation. JAMA Cardiol. 2016;1(2):172-180. 155. Haas S, Ten Cate H, Accetta G, et al. Quality of Vitamin K antagonist control and 1-year outcomes in patients with atrial brillation: a global perspective from the GARFIELD-AF registry. PloS One. 2016;11(10):e0164076. 156. Hylek EM. Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement. J Thromb Thrombolysis. 2013;35(3):333-335. 157. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial brillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-2962. 158. National Clinical Guideline C. National Institute for Health and Clinical Excellence: Guidance. Atrial Fibrillation: The Management of Atrial Fibrillation. London, United Kingdom: National Institute for Health and Care Excellence. Copyright National Clinical Guideline Centre, 2014; 2014. 159. Massaro A, Giugliano RP, Norrving B, Oto A, Veltkamp R. Overcoming global challenges in stroke prophylaxis in atrial brillation: the role of non-vitamin K antagonist oral anticoagulants. Int J Stroke. 2016;11(9):950-967. 160. Rao SR, Reisman JI, Kressin NR, et al. Explaining racial disparities in anticoagulation control: results from a study of patients at the Veterans Administration. Am J Med Qual. 2015;30(3):214-222. 161. Rose AJ, Berlowitz DR, Miller DR, et al. INR targets and site-level anticoagulation control: results from the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost. 2012;10(4): 590-595. 162. Rose AJ, Hylek EM, Berlowitz DR, Ash AS, Reisman JI, Ozonoff A. Prompt repeat testing after out-of-range INR values: a quality indicator for anticoagulation care. Circ Cardiovasc Qual Outcomes. 2011;4(3):276-282. 163. Piccini JP, Hellkamp AS, Lokhnygina Y, et al. 